Abstract

PurposeTo compare the effectiveness of percutaneous lung biopsy using a patient-mounted needle-driving robotic system with that using a manual insertion of needles under computed tomography (CT) fluoroscopy guidance. Materials and MethodsIn this institutional review board approved study, the cohort consisted of a series of patients who underwent lung biopsies following the intention-to-treat protocol from September 2022 to September 2023 using robot (n = 15) or manual insertion under single-rotation CT fluoroscopy (n = 66). Patient and procedure characteristics were recorded as well as outcomes. ResultsAlthough age, body mass index, and skin-to-target distance were not statistically different, target size varied (median, 8 mm [interquartile range, 6.5–9.5 mm] for robot vs 12 mm [8–18 mm] for single-rotation CT fluoroscopy; P = .001). No statistical differences were observed in technical success (86.7% [13/15] vs 89.4% [59/66], P = .673), Grade 3 adverse event (AE) (6.7% [1/15] vs 12.1% [8/66], P = .298), procedural time (28 minutes [22–32 minutes] vs 19 minutes [14.3–30.5 minutes], P = .086), and patient radiation dose (3.9 mSv [3.2–5.6 mSv] vs 4.6 mSv [3.3–7.5 mSv], P = .398). In robot-assisted cases, the median angle out of gantry plane was 10° (6.5°–16°), although it was null (0°–5°) for single-rotation CT fluoroscopy (P = .001). ConclusionsRobot-assisted and single-rotation CT fluoroscopy–guided percutaneous lung biopsies were similar in terms of technical success, diagnostic yield, procedural time, AEs, and radiation dose, although robot allowed for out-of-gantry plane navigation along the needle axis.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call